Cramer's 'Mad Money' Recap: Bye-Bye Big Pharma

Click here for an archive of Cramer's "Mad Money" recaps.

---

Jim Cramer can't make market players money until bonds stop going down and interest rates stop going up, he told viewers of his "Mad Money" TV show Tuesday. Until that happens, Cramer said, he's going to focus more on educating and less on stock-picking because he doesn't want to hurt people.

Everywhere Cramer goes, he is constantly asked about GlaxoSmithKline (GSK Quote - Cramer on GSK - Stock Picks), Pfizer (PFE Quote - Cramer on PFE - Stock Picks), Merck (MRK Quote - Cramer on MRK - Stock Picks), Bristol-Myers (BMY Quote - Cramer on BMY - Stock Picks) and other big drug companies, he said.

But nobody mentions aerospace, agriculture or oil services -- sectors he actually likes.

"Everyone's asking about big pharma, but I keep hoping they mean big farms," he said. Unfortunately, nobody ever does.

Cramer said he always responds in the same way, with "No, I don't like big pharma." But because it's never enough to say he doesn't like these stocks, Cramer is dedicating today's show to big pharma.

Cramer said he doesn't mind that the big drug companies are overcharging sick people. In fact, he said, he wishes they would charge even more, because that would change the bears to bulls. He said the real reason he doesn't like this sector is because the companies have lost their growth potential and haven't made any big discoveries.

But Cramer said that if he really had to, he would rather own "ultraexpensive" Celgene (CELG Quote - Cramer on CELG - Stock Picks) or Gilead Sciences (GILD Quote - Cramer on GILD - Stock Picks), because of their future growth prospects in the year 2012, than a "slow-motion" Pfizer, which will have "real problems" on its hands in 2012 because of "vicious" patent expirations that year.

« Previous Page

1 2 3 4 5

Next Page »